BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38218178)

  • 1. A systematic analysis of the landscape of synthetic lethality-driven precision oncology.
    Schäffer AA; Chung Y; Kammula AV; Ruppin E; Lee JS
    Med; 2024 Jan; 5(1):73-89.e9. PubMed ID: 38218178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic lethality on drug discovery: an update on cancer therapy.
    Yar MS; Haider K; Gohel V; Siddiqui NA; Kamal A
    Expert Opin Drug Discov; 2020 Jul; 15(7):823-832. PubMed ID: 32228106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the landscape of synthetic lethal interactions in liver cancer.
    Yang C; Guo Y; Qian R; Huang Y; Zhang L; Wang J; Huang X; Liu Z; Qin W; Wang C; Chen H; Ma X; Zhang D
    Theranostics; 2021; 11(18):9038-9053. PubMed ID: 34522226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic lethality-mediated precision oncology via the tumor transcriptome.
    Lee JS; Nair NU; Dinstag G; Chapman L; Chung Y; Wang K; Sinha S; Cha H; Kim D; Schperberg AV; Srinivasan A; Lazar V; Rubin E; Hwang S; Berger R; Beker T; Ronai Z; Hannenhalli S; Gilbert MR; Kurzrock R; Lee SH; Aldape K; Ruppin E
    Cell; 2021 Apr; 184(9):2487-2502.e13. PubMed ID: 33857424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Link synthetic lethality to drug sensitivity of cancer cells.
    Wang R; Han Y; Zhao Z; Yang F; Chen T; Zhou W; Wang X; Qi L; Zhao W; Guo Z; Gu Y
    Brief Bioinform; 2019 Jul; 20(4):1295-1307. PubMed ID: 29300844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re-defining synthetic lethality by phenotypic profiling for precision oncology.
    Akimov Y; Aittokallio T
    Cell Chem Biol; 2021 Mar; 28(3):246-256. PubMed ID: 33631125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational methods, databases and tools for synthetic lethality prediction.
    Wang J; Zhang Q; Han J; Zhao Y; Zhao C; Yan B; Dai C; Wu L; Wen Y; Zhang Y; Leng D; Wang Z; Yang X; He S; Bo X
    Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35352098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SL
    Liu Y; Wu M; Liu C; Li XL; Zheng J
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(3):748-757. PubMed ID: 30969932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-omics characterization of synthetic lethality-related molecular features: implications for SL-based therapeutic target screening.
    Weng S; Ruan H
    FEBS J; 2023 Mar; 290(6):1477-1480. PubMed ID: 36461713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inferring synthetic lethal interactions from mutual exclusivity of genetic events in cancer.
    Srihari S; Singla J; Wong L; Ragan MA
    Biol Direct; 2015 Oct; 10():57. PubMed ID: 26427375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor therapy landscape of synthetic lethality.
    Zhang B; Tang C; Yao Y; Chen X; Zhou C; Wei Z; Xing F; Chen L; Cai X; Zhang Z; Sun S; Liu Q
    Nat Commun; 2021 Feb; 12(1):1275. PubMed ID: 33627666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming selection bias in synthetic lethality prediction.
    Seale C; Tepeli Y; Gonçalves JP
    Bioinformatics; 2022 Sep; 38(18):4360-4368. PubMed ID: 35876858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Synthetic Lethality in Human Cancers via Multi-Graph Ensemble Neural Network.
    Lai M; Chen G; Yang H; Yang J; Jiang Z; Wu M; Zheng J
    Annu Int Conf IEEE Eng Med Biol Soc; 2021 Nov; 2021():1731-1734. PubMed ID: 34891621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic Lethality in Cancer Therapeutics: The Next Generation.
    Setton J; Zinda M; Riaz N; Durocher D; Zimmermann M; Koehler M; Reis-Filho JS; Powell SN
    Cancer Discov; 2021 Jul; 11(7):1626-1635. PubMed ID: 33795234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond Synthetic Lethality: Charting the Landscape of Pairwise Gene Expression States Associated with Survival in Cancer.
    Magen A; Das Sahu A; Lee JS; Sharmin M; Lugo A; Gutkind JS; Schäffer AA; Ruppin E; Hannenhalli S
    Cell Rep; 2019 Jul; 28(4):938-948.e6. PubMed ID: 31340155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A network-based approach to integrate nutrient microenvironment in the prediction of synthetic lethality in cancer metabolism.
    Apaolaza I; San José-Enériz E; Valcarcel LV; Agirre X; Prosper F; Planes FJ
    PLoS Comput Biol; 2022 Mar; 18(3):e1009395. PubMed ID: 35286311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data.
    Sinha S; Thomas D; Chan S; Gao Y; Brunen D; Torabi D; Reinisch A; Hernandez D; Chan A; Rankin EB; Bernards R; Majeti R; Dill DL
    Nat Commun; 2017 May; 8():15580. PubMed ID: 28561042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSSLdb: Discovery of cancer-specific synthetic lethal interactions based on machine learning and statistic inference.
    Dou Y; Ren Y; Zhao X; Jin J; Xiong S; Luo L; Xu X; Yang X; Yu J; Guo L; Liang T
    Comput Biol Med; 2024 Mar; 170():108066. PubMed ID: 38310806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.